BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17119039)

  • 1. Reproductive factors, oral contraceptive use, and human papillomavirus infection: pooled analysis of the IARC HPV prevalence surveys.
    Vaccarella S; Herrero R; Dai M; Snijders PJ; Meijer CJ; Thomas JO; Hoang Anh PT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Ronco G; Rajkumar R; Qiao YL; Muñoz N; Franceschi S
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2148-53. PubMed ID: 17119039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys.
    Vaccarella S; Franceschi S; Herrero R; Muñoz N; Snijders PJ; Clifford GM; Smith JS; Lazcano-Ponce E; Sukvirach S; Shin HR; de Sanjosé S; Molano M; Matos E; Ferreccio C; Anh PT; Thomas JO; Meijer CJ;
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):326-33. PubMed ID: 16492924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of human papillomavirus-related cervical tumors to cigarette smoking, oral contraceptive use, and prior herpes simplex virus type 2 infection.
    Daling JR; Madeleine MM; McKnight B; Carter JJ; Wipf GC; Ashley R; Schwartz SM; Beckmann AM; Hagensee ME; Mandelson MT; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):541-8. PubMed ID: 8827359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys.
    Vaccarella S; Herrero R; Snijders PJ; Dai M; Thomas JO; Hieu NT; Ferreccio C; Matos E; Posso H; de Sanjosé S; Shin HR; Sukvirach S; Lazcano-Ponce E; Muñoz N; Meijer CJ; Franceschi S;
    Int J Epidemiol; 2008 Jun; 37(3):536-46. PubMed ID: 18316350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human papillomavirus infection in women in Turin, Italy.
    Ronco G; Ghisetti V; Segnan N; Snijders PJ; Gillio-Tos A; Meijer CJ; Merletti F; Franceschi S
    Eur J Cancer; 2005 Jan; 41(2):297-305. PubMed ID: 15661556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
    Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking.
    Castellsagué X; Muñoz N
    J Natl Cancer Inst Monogr; 2003; (31):20-8. PubMed ID: 12807941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
    Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
    Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sociodemographic factors associated with high-risk human papillomavirus infection.
    Kahn JA; Lan D; Kahn RS
    Obstet Gynecol; 2007 Jul; 110(1):87-95. PubMed ID: 17601901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of second pregnancy on maternal carriage and outcome of high-risk human papillomavirus (HPV). Experience from the prospective finnish family HPV study.
    Sarkola ME; Grénman SE; Rintala MA; Syrjanen KJ; Syrjanen SM
    Gynecol Obstet Invest; 2009; 67(3):208-16. PubMed ID: 19287178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
    Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concurrent infection with multiple human papillomavirus types: pooled analysis of the IARC HPV Prevalence Surveys.
    Vaccarella S; Franceschi S; Snijders PJ; Herrero R; Meijer CJ; Plummer M;
    Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):503-10. PubMed ID: 20142247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical squamous cells of undetermined significance: human papillomavirus testing in adolescents.
    Boardman LA; Stanko C; Weitzen S; Sung CJ
    Obstet Gynecol; 2005 Apr; 105(4):741-6. PubMed ID: 15802399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International correlation between human papillomavirus prevalence and cervical cancer incidence.
    Maucort-Boulch D; Franceschi S; Plummer M;
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):717-20. PubMed ID: 18349293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda.
    Safaeian M; Kiddugavu M; Gravitt PE; Gange SJ; Ssekasanvu J; Murokora D; Sklar M; Serwadda D; Wawer MJ; Shah KV; Gray R
    Sex Transm Infect; 2008 Aug; 84(4):306-11. PubMed ID: 18385223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genital human papillomavirus screening by gene chip in Chinese women of Guangdong province.
    Lin M; Yang LY; Li LJ; Wu JR; Peng YP; Luo ZY
    Aust N Z J Obstet Gynaecol; 2008 Apr; 48(2):189-94. PubMed ID: 18366494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genital human papillomavirus infection in women from the Zagreb region.
    Marijan T; Vranes J; Mlinarić-Dzepina A; Leskovar V; Knezević J; Kvaternik M
    Coll Antropol; 2007 Apr; 31 Suppl 2():83-7. PubMed ID: 17600936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.